Erocin

Erocin may be available in the countries listed below.

Ingredient matches for Erocin

Erythromycin

Erythromycin is reported as an ingredient of Erocin in the following countries:

• Bangladesh


• Oman

International Drug Name Search

ropivacaine Injection

roe-PIV-a-kane

Commonly used brand name(s)

In the U.S.

• Naropin

Available Dosage Forms:

• Solution

Therapeutic Class: Anesthetic, Local

Chemical Class: Amino Amide

Uses For ropivacaine

Ropivacaine is a local anesthetic given by injection to cause loss of feeling before and during surgery or labor and delivery. It does not cause loss of consciousness.

Ropivacaine is given only by or under the immediate supervision of a medical doctor, or by a specially trained nurse, in the doctor's office or in a hospital.

Before Using ropivacaine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For ropivacaine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to ropivacaine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Studies on ropivacaine have been done only in adolescents and adults, and there is no specific information comparing use of ropivacaine in children with use in other age groups.

Geriatric

Many medicines have not been specifically studied in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of ropivacaine in the elderly with use in other age groups. Based on information about similar medicines, it is expected that elderly people will be more sensitive than younger adults to the effects of ropivacaine. This may increase the chance of side effects.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	B	Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking ropivacaine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.

Using ropivacaine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Hyaluronidase


• St John's Wort

Using ropivacaine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.

• Ciprofloxacin


• Fluvoxamine

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of ropivacaine. Make sure you tell your doctor if you have any other medical problems, especially:

• Heart disease—ropivacaine may make your condition worse

• Kidney disease or


• Liver disease—Side effects may be more likely in patients with kidney disease or liver disease

Proper Use of ropivacaine

Dosing

The dose of ropivacaine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of ropivacaine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• Your age;


• Your general physical condition;


• The reason the medicine is being given; and


• Other medicines you are taking or will receive before or after ropivacaine is given.

Precautions While Using ropivacaine

For patients going home before the numbness or loss of feeling caused by ropivacaine wears off:

• During the time that the injected area feels numb, serious injury can occur without your knowing it. Be especially careful to avoid injury until the medicine wears off or feeling returns to the area.

ropivacaine Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Less common or rare

• Burning or prickling sensation


• fever


• itching

Check with your doctor as soon as possible if any of the following side effects occur:

Less common or rare

• Back pain


• difficulty urinating


• headache


• pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: ropivacaine Injection side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More ropivacaine Injection resources

• Ropivacaine Injection Side Effects (in more detail)
• Ropivacaine Injection Use in Pregnancy & Breastfeeding
• Ropivacaine Injection Drug Interactions
• Ropivacaine Injection Support Group
• 0 Reviews for Ropivacaine Injection - Add your own review/rating

Compare ropivacaine Injection with other medications

• Cesarean Section
• Labor Pain
• Local Anesthesia

Oryant

Oryant may be available in the countries listed below.

Ingredient matches for Oryant

Cefazolin

Cefazolin sodium salt (a derivative of Cefazolin) is reported as an ingredient of Oryant in the following countries:

• Philippines

International Drug Name Search

Faringodol

Faringodol may be available in the countries listed below.

Ingredient matches for Faringodol

Choline Salicylate

Choline Salicylate is reported as an ingredient of Faringodol in the following countries:

• Estonia


• Lithuania

International Drug Name Search

Lomedium

Lomedium may be available in the countries listed below.

Ingredient matches for Lomedium

Loperamide

Loperamide hydrochloride (a derivative of Loperamide) is reported as an ingredient of Lomedium in the following countries:

• Vietnam

International Drug Name Search

Coszol

Coszol may be available in the countries listed below.

Ingredient matches for Coszol

Omeprazole

Omeprazole is reported as an ingredient of Coszol in the following countries:

• India

International Drug Name Search

Zyflon

Zyflon may be available in the countries listed below.

Ingredient matches for Zyflon

Buflomedil

Buflomedil is reported as an ingredient of Zyflon in the following countries:

• Tunisia

International Drug Name Search

Oestriol Mylan

Oestriol Mylan may be available in the countries listed below.

Ingredient matches for Oestriol Mylan

Estriol

Estriol is reported as an ingredient of Oestriol Mylan in the following countries:

• Sweden

International Drug Name Search

Milrinone

In the US, Milrinone (milrinone systemic) is a member of the drug class inotropic agents and is used to treat Heart Failure.

US matches:

• Milrinone


• Milrinone Lactate


• Milrinone Dextrose


• Milrinone Injection


• Milrinone Lactate in Dextrose Injection

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C01CE02

CAS registry number (Chemical Abstracts Service)

0078415-72-2

Chemical Formula

C12-H9-N3-O

Molecular Weight

211

Therapeutic Categories

Cardiac stimulant, cardiotonic agent

Vasodilator

Chemical Name

[3,4'-Bipyridine]-5-carbonitrile, 1,6-dihydro-2-methyl-6-oxo-

Foreign Names

• Milrinonum (Latin)
• Milrinon (German)
• Milrinone (French)
• Milrinona (Spanish)

Generic Names

• Milrinone (OS: BAN, USAN, DCF)
• Win 47203-2 (IS: SterlingWinthr)
• Milrinone (PH: USP 32)

Brand Names

• Coritrope
  Sanofi-Aventis, Indonesia



• Corotrop
  Sanofi-Aventis, Austria; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Czech Republic; Sanofi-Aventis, Germany



• Corotrope
  Sanofi Aventis, Tunisia; Sanofi-Aventis, Argentina; Sanofi-Aventis, Belgium; Sanofi-Aventis, France; Sanofi-Aventis, Hungary; Sanofi-Aventis, Poland; Sanofi-Aventis, Slovakia; Sanofi-Aventis S.A., Spain; Sanofi-Synthelabo, Greece; Sanofi-Synthelabo, Luxembourg; Sanofi-Synthelabo, Peru



• Milicor
  Samarth, India



• Milrila
  Astellas, Japan



• Milrila K
  Astellas, Japan



• Milrinon Labatec
  Labatec, Switzerland



• Milrinone Xin Shi Dai Pharm
  Xin Shi Dai Pharm, China



• Primacor
  Sanofi-Aventis, Israel



• Apo-Milrinone
  Apotex, Canada



• Corotrop
  Sanofi-Aventis, Sweden



• Corotrope
  Sanofi-Aventis, Chile; Sanofi-Aventis, Colombia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Venezuela



• Milrinone Lactate Injection
  Bedford, United States



• Milrinone Lactate
  Apotex, United States; APP, United States; Baxter, United States; Bedford, United States; Ben Venue, Israel; Bioniche, United States; Gland, United States; Hikma, United States; Hospira, United States; International Medication Systems, United States; Mayne, United States



• Primacor
  Sanofi-Aventis, Australia; Sanofi-Aventis, Brazil; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Mexico; Sanofi-Aventis, Malaysia; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Singapore; Sanofi-Aventis, Thailand; Sanofi-Aventis, Taiwan; Sanofi-Aventis, United States

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Volero

Volero may be available in the countries listed below.

Ingredient matches for Volero

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Volero in the following countries:

• Myanmar

International Drug Name Search

Boxazin plus C

Boxazin plus C may be available in the countries listed below.

Ingredient matches for Boxazin plus C

Aspirin

Acetylsalicylic Acid is reported as an ingredient of Boxazin plus C in the following countries:

• Germany

Ascorbic Acid

Ascorbic Acid is reported as an ingredient of Boxazin plus C in the following countries:

• Germany

International Drug Name Search

Epalon

Epalon may be available in the countries listed below.

Ingredient matches for Epalon

Maprotiline

Maprotiline hydrochloride (a derivative of Maprotiline) is reported as an ingredient of Epalon in the following countries:

• Cyprus

International Drug Name Search